A New Class of Water-Soluble Cyclophanes
J. Am. Chem. Soc., Vol. 121, No. 7, 1999 1457
6.87 (s, 1 H); 13C NMR (CDCl3) δ 57.00, 71.05, 75.03, 79.31, 114.65,
119.60, 138.79, 156.23; MS m/e (rel intensity) 230 (M+, 7%).
3-(N,N′-Dimethylamino)propyl Methanesulfonate Hydrochloride
(20). To a CH2Cl2 (100 mL) solution of 3-(N,N′-dimethylamino)-1-
propanol (5.00 g, 48.5 mmol) was added methanesulfonyl chloride (13.9
g, 120 mmol) dropwise at 0 °C. After the solution was stirred 6 h at
room temperature, the resulting precipitate was filtered to afford 20:
yield 100% (10.6 g); IR (KBr) 3585, 2921, 2670, 2474, 2360, 1481,
reaction mixture was stirred at that temperature for 2 days. After
removal of the solvent, the residue was dissolved in water and extracted
with CHCl3. The CHCl3 extract was evaporated and chromatographed
(silica gel; eluent, CH2Cl2:Et3N ) 40:1). The eluent was corrected and
evaporated. The residue was washed with MeOH to give 1: yield 8%
(88 mg); IR (KBr) 3170, 2854, 2684, 1743, 1596, 1456, 1351, 1297,
1
1166, 1062 cm-1; H NMR (CDCl3) δ 2.05 (m, 4 H), 2.30 (s, 12 H),
4.12 (t, J ) 6.7 Hz, 4 H), 4.62 (s, 8 H), 4.93 (s, 8 H), 7.05 (s, 4 H),
7.44 (s, 2 H), 7.51 (d, J ) 7.9 Hz, 4 H), 7.60 (d, J ) 9.2 Hz, 4 H),
7.78 (d, J ) 7.9 Hz, 4 H), 8.21 (d, J ) 9.2 Hz, 2 H); 13C NMR (CDCl3)
δ 45.58, 56.47, 57.48, 66.44, 71.03, 85.82, 90.61, 114.35, 117.16,
124.78, 125.54, 127.61, 129.55, 130.13, 130.50, 131.65, 134.64, 138.95,
157.14; FABMS (in 3-nitrobenzyl alcohol) m/e (rel intensity) 1028
(MH+, 54%).
1
1336, 1267, 1174, 1014 cm-1; H NMR (DMSO-d6) δ 2.12 (m, 2 H),
2.73 (d, J ) 4.9 Hz, 6 H), 3.10 (m, 2 H), 3.22 (s, 3 H), 4.30 (t, J ) 6.1
Hz, 2 H), 10.92 (br s, 1 H); 13C NMR (DMSO-d6) δ 23.89, 36.87,
42.15, 53.26, 67.82; FABMS (in 3-nitrobenzyl alcohol) m/e (rel
intensity) 182 (M+ - Cl, 100%).
1,3-Bis(propargyloxymethyl)-5-[3-(N,N′-dimethylamino)propoxy]-
benzene (12). To a DMF (25 mL) suspension of NaH (0.63 g, 15.7
mmol; commercial 60% dispersion was washed thoroughly with hexane
prior to use) was added a DMF (10 mL) solution of 19 (1.76 g, 7.50
mmol) dropwise at 0 °C. After the solution was stirred 1 h at that
temperature, 20 (1.71 g, 7.85 mmol) was added by portions at 0 °C.
The reaction mixture was warmed to room temperature gradually and
stirred at that temperature for an additional 12 h. After removal of the
solvent, the residue was dissolved in water and extracted with CHCl3.
The CHCl3 extract was evaporated and chromatographed (silica gel;
eluent, CH2Cl2:MeOH ) 8:1) to give 12: yield 90% (2.13 g); oil; IR
(KBr) 3291, 2945, 2860, 2767, 1599, 1458, 1167, 1086 cm-1; 1H NMR
(CDCl3) δ 1.95 (m, 2H), 2.26 (s, 6 H), 2.46 (t, J ) 7.9 Hz, 2 H), 2.50
(t, J ) 2.4 Hz, 2 H), 4.04 (t, J ) 8.5 Hz, 2 H), 4.17 (d, J ) 2.4 Hz,
4 H), 4.56 (s, 4 H), 6.85 (s, 2 H), 6.91 (s, 1 H); 13C NMR (CDCl3) δ
27.26, 45.25, 56.21, 57.00, 66.03, 71.13, 74.06, 79.44, 113.34, 119.56,
138.83, 159.20; MS m/e (rel intensity) 316 (MH+, 100%).
Bis(alkynylstannane) Derivative 13. To a THF (25 mL) solution
of 12 (1.13 g, 3.58 mmol) was added a n-hexane solution of n-BuLi
(7.15 mmol) dropwise at 0 °C. After the solution was stirred 1 h at
that temperature, tributyltin(IV) chloride (2.46 g, 7.54 mmol) was added.
The reaction mixture was warmed to room temperature gradually and
stirred at that temperature for an additional 12 h. After removal of the
solvent, the residue was dissolved in saturated potassium fluoride
aqueous solution and extracted with Et2O. The Et2O extract was filtered
and evaporated to give crude 13. This compound was used in the next
reaction without further purification: yield 100% (3.20 g); oil; IR (KBr)
2956, 2927, 2854, 1598, 1521, 1457, 1375, 1294, 1164, 1082 cm-1;1H
NMR (CDCl3) δ 0.90 (t, J ) 7.3 Hz 18 H), 1.01 (m, 12 H), 1.34 (m,
12 H), 1.94 (m, 2 H), 2.25 (s, 6 H), 2.44 (t, J ) 6.7 Hz 2 H), 4.01 (t,
J ) 6.7 Hz 2 H), 4.18 (t, J ) 4.3 Hz 4 H), 4.57 (s, 4 H), 6.85 (s, 2 H),
6.90 (s, 1 H); 13C NMR (CDCl3) δ 10.93, 13.55, 26.86, 27.54, 28.76,
45.41, 56.33, 58.05, 66.04, 70.79, 89.87, 105.59, 113.29, 119.60, 139.23,
159.24; FABMS (in 3-nitrobenzyl alcohol) m/e (rel intensity) 892
(MH+, 100%).
Pyrenophane 2. To a CH2Cl2 (2 mL) solution of 1 (41 mg, 0.040
mmol) was added methyl trifluoromethanesulfonate (66 mg, 0.40 mmol)
dropwise at 0 °C. The reaction mixture was stirred at that temperature
for 1 h. After removal of the solvent at 0 °C, the residue was washed
sequentially with hexane, Et2O, and CH2Cl2 to afford 2: yield 92%
(50 mg); IR (KBr) 2854, 1601, 1487, 1259, 1165, 1029 cm-1; 1H NMR
(CD3OD) δ 2.35 (br m, 4 H), 3.23 (s, 18 H), 3.65 (m, 4 H), 4.27 (t, J
) 5.5 Hz, 4 H), 4.69 (s, 8 H), 5.01 (s, 8 H), 7.16 (s, 4 H), 7.53 (d, J
) 9.2 Hz, 4 H), 7.58 (d, J ) 7.9 Hz, 4 H), 7.62 (s, 2 H), 7.77 (d, J )
7.9 Hz, 2 H), 8.03 (d, J ) 9.2 Hz, 2 H); 13C NMR (CD3OD) δ 26.34,
30.02, 53.49, 53.71, 58.42, 72.06, 77.91, 86.58, 91.96, 115.25, 118.28,
123.92, 125.96, 126.22, 128.59, 130.47, 131.66, 132.53, 140.88, 144.60,
151.31; FABMS (in 3-nitrobenzyl alcohol) m/e (rel intensity) 1205 (M+
- OTf, 100%).
Pyrenophane 3. A THF (5 mL) suspension of 1 (26 mg, 0.025
mmol) and PtO2 (3 mg) was stirred at room temperature for 12 h under
hydrogen at a pressure of 1 atm. The reaction mixture was filtered
through Celite. The filtrate was evaporated and washed with MeOH to
give 3: yield 95% (25 mg); IR (KBr) 2940, 2864, 1597, 1456, 1362,
1
1294, 1103, 1063 cm-1; H NMR (CDCl3) δ 2.09 (m, 12 H), 2.37 (s,
12 H), 2.61 (t, J ) 7.3 Hz, 4 H), 3.36 (t, J ) 7.9 Hz, 8 H), 3.59 (t, J
) 6.1 Hz, 8 H), 4.08 (t, J ) 6.1 Hz, 4 H), 4.56 (s, 8 H), 6.84 (s, 4 H),
7.29 (s, 2 H), 7.52-7.67 (m, 12 H), 8.01 (d, J ) 9.2 Hz, 4 H); 13C
NMR (CDCl3) δ 27.42, 30.17, 31.87, 45.35, 53.86, 56.43, 69.61, 72.84,
112.87, 119.02, 122.25, 124.25, 125.04, 126.88, 127.06, 128.72, 129.28,
135.77, 140.58, 159.14; FABMS (in 3-nitrobenzyl alcohol) m/e (rel
intensity) 1043 (MH+, 100%).
Pyrenophane 4. This compound was synthesized from 3 (35 mg,
0.034 mmol) in a manner similar to that described for 2. 4: yield 97%
(45 mg); IR (KBr) 2939, 2862, 1601, 1487, 1259, 1163, 1032 cm-1
;
1H NMR (DMSO-d6) δ 2.08 (m, 8 H), 2.24 (m, 4 H), 2.84 (m, 4 H),
3.11(s, 18 H), 3.52 (m, 12 H), 4.12 (t, J ) 6.1 Hz, 8 H), 4.55 (s, 8 H),
6.87 (s, 4 H), 7.26 (s, 2 H), 7.58 (d, J ) 7.9 Hz, 12 H), 7.68 (d, J )
7.9 Hz, 12 H), 7.74 (d, J ) 9.2 Hz, 4 H), 8.05 (d, J ) 9.2 Hz, 4 H);
13C NMR (DMSO-d6) δ 22.81, 29.61, 31.80, 52.47, 63.23, 64.93, 69.14,
71.87, 112.61, 119.57, 122.14, 124.49, 127.13, 128.26, 128.88, 136.08,
140.77, 158.29; FABMS (in 3-nitrobenzyl alcohol) m/e (rel intensity)
1221 (M+ - OTf, 100%).
Bis(bromopyrene) Derivative 14. A morpholine (270 mL) suspen-
sion of 1,6-dibromopyrene21 (4.39 g, 12.1 mmol), (PPh3)2PdCl2 (143
mg, 0.20 mmol), and CuI (18.9 mg, 0.10 mmol) was stirred at 80 °C
until the reaction mixture became homogeneous. To the solution was
added 12 (0.96 g, 3.06 mmol). The reaction mixture was stirred at that
temperature for an additional 12 h. After removal of the solvent, the
residue was dissolved in water and extracted with CHCl3. The CHCl3
extract was evaporated and chromatographed (silica gel; eluent, CHCl3:
EtOH ) 8:1) to give 14: yield 40% (1.07 g); IR (KBr) 3291, 2945,
Acyclic Analogue 5. The THP-protected intermediate of 5 was
derived from 1,6-dibromopyrene21 (180 mg, 0.50 mmol) and 2-(1,4-
dioxahept-6-ynyl)tetrahydropyran23 (230 mg, 1.25 mmol) in a manner
similar to that described for 14. Deprotection of the intermediate was
carried out in a manner similar to that described for 19 to give 5: yield
(from 1,6-dibromopyrene in two steps) 35% (70 mg); IR (KBr) 3750,
1
2860, 2767, 1599, 1458, 1167, 1086 cm-1; H NMR (CDCl3) δ 1.98
3290, 2888, 1706, 1598, 1436, 1351, 1261, 1112, 1074, 1024 cm-1
;
(m, 2 H), 2.25 (s, 6 H), 2.46 (t, J ) 6.7 Hz, 2 H), 4.08 (t, J ) 6.1 Hz,
2 H), 4.64 (s, 4 H), 4.83 (s, 4 H), 7.01 (s, 2 H), 7.22 (s, 1 H), 7.77 (d,
J ) 8.5 Hz, 2 H), 7.84 (d, J ) 9.2 Hz, 2 H), 7.87 (d, J ) 8.5 Hz, 2 H),
7.90 (d, J ) 7.9 Hz, 2 H), 8.00 (d, J ) 7.9 Hz, 2 H), 8.06 (d, J ) 7.9
Hz, 2 H), 8.22 (d, J ) 9.2 Hz, 2 H), 8.36 (d, J ) 8.5 Hz, 2 H); 13C
NMR (CDCl3) δ 27.42, 45.35, 56.35, 58.25, 66.27, 71.61, 85.50, 91.06,
113.82, 117.70, 120.31, 120.45, 123.40, 124.72, 125.04, 125.42, 125.87,
126.52, 127.83, 128.44, 129.41, 130.15, 130.21, 130.86, 131.83, 139.31,
159.61; FABMS (in 3-nitrobenzyl alcohol) m/e (rel intensity) 877 (M+
+ 2, 42%).
1H NMR (CDCl3) δ 3.87 (s, 8 H), 4.68 (s, 4 H), 8.11 (m, 6 H), 8.55
(d, J ) 9.2 Hz, 2 H); 13C NMR (CDCl3) δ 59.62, 61.95, 71.43, 85.44,
90.84, 117.70, 120.45, 125.12, 126.23, 128.23, 130.27, 131.27, 132.17;
FABMS (in 3-nitrobenzyl alcohol) m/e (rel intensity) 398 (M+, 13%).
Acyclic Analogue 6. This compound was synthesized from 1,6-
dibromopyrene21 (500 mg, 1.39 mmol) and 1-(N,N′-dimethylamino)-
2-propyne (289 mg, 3.47 mmol) in a manner similar to that described
for 14. 6: yield 36% (183 mg); mp 152-153 °C; IR (KBr) 2939, 2863,
1
1603, 1462, 1321, 1157, 1038 cm-1; H NMR (CDCl3) δ 2.52 (s, 12
Pyrenophane 1. To a toluene (450 mL) solution of 14 (938 mg,
1.07 mmol) and (PPh3)2PdCl2 (50 mg, 0.0712 mmol) was added a
toluene (50 mL) solution of 13 (1054 mg, 1.18 mmol) at 50 °C. The
(23) Inouye, M.; Akamatsu, K.; Nakazumi, H. J. Am. Chem. Soc. 1997,
119, 9160-9165.